Format
Sort by
Items per page

Send to

Choose Destination

Best matches for resveratrol ovarian cancer:

Search results

Items: 1 to 20 of 108

1.

Resveratrol induces immunogenic cell death of human and murine ovarian carcinoma cells.

Zhang Y, Yang S, Yang Y, Liu T.

Infect Agent Cancer. 2019 Oct 18;14:27. doi: 10.1186/s13027-019-0247-4. eCollection 2019.

2.

The apoptotic effect of resveratrol in ovarian cancer cells is associated with downregulation of galectin-3 and stimulating miR-424-3p transcription.

El-Kott AF, Shati AA, Ali Al-Kahtani M, Alharbi SA.

J Food Biochem. 2019 Oct 11:e13072. doi: 10.1111/jfbc.13072. [Epub ahead of print]

PMID:
31603261
3.

Efficacy and safety of intraperitoneally administered resveratrol against rat orthotopic ovarian cancers.

Zhong LX, Wu ML, Li H, Liu J, Lin LZ.

Cancer Manag Res. 2019 Jul 4;11:6113-6124. doi: 10.2147/CMAR.S206301. eCollection 2019.

4.

Corrigendum to: EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: Inhibition by resveratrol.

[No authors listed]

Mol Oncol. 2019 Jun;13(6):1462-1464. doi: 10.1002/1878-0261.12495. Epub 2019 May 8. No abstract available.

5.

Mechanistic perspective of protective effects of resveratrol against cisplatin-induced ovarian injury in rats: emphasis on anti-inflammatory and anti-apoptotic effects.

Said RS, Mantawy EM, El-Demerdash E.

Naunyn Schmiedebergs Arch Pharmacol. 2019 Oct;392(10):1225-1238. doi: 10.1007/s00210-019-01662-x. Epub 2019 May 25.

PMID:
31129703
6.

Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer.

Fatease AA, Shah V, Nguyen DX, Cote B, LeBlanc N, Rao DA, Alani AWG.

Nanomedicine. 2019 Jul;19:39-48. doi: 10.1016/j.nano.2019.03.011. Epub 2019 Apr 22.

PMID:
31022465
7.

Resveratrol induces cell death through ROS‑dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells.

Kim TH, Park JH, Woo JS.

Mol Med Rep. 2019 Apr;19(4):3353-3360. doi: 10.3892/mmr.2019.9962. Epub 2019 Feb 15.

PMID:
30816513
8.

Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways.

Dull AM, Moga MA, Dimienescu OG, Sechel G, Burtea V, Anastasiu CV.

Molecules. 2019 Feb 13;24(4). pii: E667. doi: 10.3390/molecules24040667. Review.

9.

Resveratrol alleviates chemotherapy-induced oogonial stem cell apoptosis and ovarian aging in mice.

Wu M, Ma L, Xue L, Ye W, Lu Z, Li X, Jin Y, Qin X, Chen D, Tang W, Chen Y, Hong Z, Zhang J, Luo A, Wang S.

Aging (Albany NY). 2019 Feb 14;11(3):1030-1044. doi: 10.18632/aging.101808. [Epub ahead of print]

10.

Resveratrol potentially increased the tumoricidal effect of doxorubicin on SKOV3 cancer stem cells in vitro.

Pouyafar A, Zadi Heydarabad M, Aghdam SB, Khaksar M, Azimi A, Rahbarghazi R, Talebi M.

J Cell Biochem. 2019 Jan 4. doi: 10.1002/jcb.28129. [Epub ahead of print]

PMID:
30609135
11.

DHS (trans-4,4'-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2).

Chen CW, Li Y, Hu S, Zhou W, Meng Y, Li Z, Zhang Y, Sun J, Bo Z, DePamphilis ML, Yen Y, Han Z, Zhu W.

Oncogene. 2019 Mar;38(13):2364-2379. doi: 10.1038/s41388-018-0584-6. Epub 2018 Dec 5.

12.

Effect of autophagy on the resveratrol-induced apoptosis of ovarian cancer SKOV3 cells.

Wang H, Peng Y, Wang J, Gu A, Li Q, Mao D, Guo L.

J Cell Biochem. 2018 Nov 18. doi: 10.1002/jcb.28053. [Epub ahead of print]

PMID:
30450764
13.

Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry.

Rogers-Broadway KR, Kumar J, Sisu C, Wander G, Mazey E, Jeyaneethi J, Pados G, Tsolakidis D, Klonos E, Grunt T, Hall M, Chatterjee J, Karteris E.

Int J Mol Med. 2019 Jan;43(1):47-56. doi: 10.3892/ijmm.2018.3967. Epub 2018 Oct 31.

14.

Food-derived polyphenols inhibit the growth of ovarian cancer cells irrespective of their ability to induce antioxidant responses.

Kwon Y.

Heliyon. 2018 Aug 29;4(8):e00753. doi: 10.1016/j.heliyon.2018.e00753. eCollection 2018 Aug.

15.

Correction to: Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression.

Kim SH, Cho KH, Kim YN, Jeong BY, Park CG, Hur GM, Lee HY.

Arch Pharm Res. 2018 Sep;41(9):938-940. doi: 10.1007/s12272-018-1073-8.

PMID:
30171520
16.

A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for Ovarian Serous Cystadenocarcinoma.

Xiong DD, Qin Y, Xu WQ, He RQ, Wu HY, Wei DM, Zeng JJ, Dang YW, Chen G.

Clin Drug Investig. 2018 Oct;38(10):909-925. doi: 10.1007/s40261-018-0683-8.

PMID:
30097905
17.

Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway.

Wen W, Lowe G, Roberts CM, Finlay J, Han ES, Glackin CA, Dellinger TH.

Int J Mol Sci. 2018 Jul 7;19(7). pii: E1983. doi: 10.3390/ijms19071983.

18.

Development of Resveratrol-Loaded Herbal Extract-Based Nanocomposites and Their Application to the Therapy of Ovarian Cancer.

Nam S, Lee SY, Kang WS, Cho HJ.

Nanomaterials (Basel). 2018 May 31;8(6). pii: E384. doi: 10.3390/nano8060384.

19.

Effects of different drug treatments on the proliferation of human ovarian carcinoma cell line MDAH-2774

Ayla Ş, Bilir A, Ertürkoğlu Ş, Tanrıverdi G, Soner BC, Sofuoğlu K, Ghisolfi L, Öktem G.

Turk J Med Sci. 2018 Apr 30;48(2):441-448. doi: 10.3906/sag-1507-193.

PMID:
29714468

Supplemental Content

Loading ...
Support Center